Skip to main content
. Author manuscript; available in PMC: 2025 Aug 19.
Published in final edited form as: Ann Rheum Dis. 2016 Nov 28;76(6):1031–1035. doi: 10.1136/annrheumdis-2016-210152

Table 3.

The association of infections with incident giant cell arteritis

Exposure Unadjusted IRR (95% CI) p Value Adjusted IRR (95% CI)* p Value
Herpes zoster infection 1.24 (1.10 to 1.39) <0.01 1.17 (1.04 to 1.32) <0.01
Herpes zoster infection and antiviral therapy 1.16 (0.99 to 1.36) 0.05 1.09 (0.93 to 1.28) 0.27
Any infection 1.44 (1.34 to 1.56) <0.01 1.26 (1.16 to 1.36) <0.01
No. of infections
0 1 (reference) 1 (reference)
1 1.38 (1.27 to 1.50) <0.01 1.28 (1.18 to 1.40) <0.01
2–4 1.88 (1.71 to 2.08) <0.01 1.60 (1.44 to 1.77) <0.01
5 or more 2.94 (2.58 to 3.36) <0.01 2.18 (1.90 to 2.51) <0.01
Test for trend <0.01 Test for trend <0.01
*

Adjusted for Charlson Comorbidity Index, alcohol use, smoking history, prior use of immunosuppressive therapies and prior use of oral glucocorticoids.

IRR, incident rate ratio.